0.6341
Schlusskurs vom Vortag:
$0.632
Offen:
$0.629
24-Stunden-Volumen:
110.78K
Relative Volume:
0.01
Marktkapitalisierung:
$14.08M
Einnahmen:
$137.00K
Nettoeinkommen (Verlust:
$-24.37M
KGV:
-0.4267
EPS:
-1.4862
Netto-Cashflow:
$-15.97M
1W Leistung:
-8.10%
1M Leistung:
+24.26%
6M Leistung:
-35.62%
1J Leistung:
-49.47%
Adagio Medical Holdings Inc Stock (ADGM) Company Profile
Firmenname
Adagio Medical Holdings Inc
Sektor
Branche
Telefon
(949) 348-1188
Adresse
26051 MERIT CIRCLE, LAGUNA HILLS
Compare ADGM vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
ADGM
Adagio Medical Holdings Inc
|
0.6341 | 14.04M | 137.00K | -24.37M | -15.97M | -1.4862 |
|
ABT
Abbott Laboratories
|
114.14 | 198.01B | 46.59B | 5.41B | 7.38B | 3.0938 |
|
SYK
Stryker Corp
|
327.70 | 130.41B | 25.27B | 3.34B | 4.57B | 8.6334 |
|
MDT
Medtronic Plc
|
92.30 | 120.48B | 36.36B | 4.84B | 5.43B | 3.7261 |
|
BSX
Boston Scientific Corp
|
49.37 | 75.37B | 20.62B | 3.56B | 3.48B | 2.3847 |
|
EW
Edwards Lifesciences Corp
|
89.83 | 53.19B | 6.30B | 1.07B | 1.09B | 1.8406 |
Adagio Medical Holdings Inc Stock (ADGM) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-04-14 | Eingeleitet | Piper Sandler | Overweight |
| 2025-12-02 | Eingeleitet | Lake Street | Buy |
Adagio Medical Holdings Inc Aktie (ADGM) Neueste Nachrichten
Midday Stock Roundup: Eledon Falls 3.5% - Orange County Business Journal
ADGM Q1 2026 Earnings: Wider-than-Expected Loss Reflects Pre-Revenue Investment PhaseEarnings Decline Risk - Vinanet
US Micro Cap StocksInvest from India - INDmoney
Adagio Medical Faces Nasdaq Delisting Risk on Negative Stockholders’ Equity - Minichart
Adagio Medical Receives Nasdaq Listing Deficiency Notice - TipRanks
Adagio Medical (ADGM): ADAR1 Capital discloses 1.21M-share, 5.4% beneficial stake - Stock Titan
Adagio Medical Holdings Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Adagio Medical Holdings Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView
Adagio Medical Expects FDA Approval for VT Ablation Catheter by Q4 2026 - Minichart
Adagio Medical Highlights VT Ablation Progress in Presentation - TipRanks
Adagio Medical updates investor presentation; expects FDA PMA approval for vCLAS in Q4 2026, $7.7M cash - TradingView
Adagio Medical Holdings Inc expected to post a loss of 28 cents a shareEarnings Preview - TradingView
Adagio Q2 Net Loss Widens to $6.7M - Orange County Business Journal
Adagio Medical (ADGM) Advances Clinical Milestones Amid High Pri - GuruFocus
Form 8K Adagio Medical Holdings Inc For: 11 August By Investing.com - Investing.com Canada
Adagio Medical (NASDAQ: ADGM) posts Q2 2026 loss and warns on cash runway - Stock Titan
Adagio Medical Holdings, Inc. 2026: Revenue $4.93M, EPS ($0.3) — 10-Q Summary - TradingView
Adagio Medical Q2 Net Loss Widens to $6.7 Million - Quiver Quantitative
Adagio Medical reports Q2 2026 net loss of $6.7M, cash $7.7M - TradingView
Adagio Medical Reports Second Quarter 2026 Results - Business Wire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
ADGM Q1 2026 Earnings: Pre-Revenue Loss Misses by 4.27%; Shares Rise 7.17%Downward Estimate Revision - Vinanet
ADGM Q1 2026 Earnings: Wider-Than-Expected Loss Sends Shares Down 6.69%Guidance Downgrade Alert - Vinanet
Adagio Medical Company Profile & Introduction - Moomoo
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
ADGM stock surges as investors react to next-generation ULTA milestone - Quiver Quantitative
Traders are paying attention to the gapping stocks in Tuesday's session. - ChartMill
Adagio Medical Stock Is Trending Overnight: Here's Why ADGM Jumped 22% After Hours - Benzinga
Adagio Medical treats first patient with next-generation VT ablation catheter under FDA expanded access - Medical Economics
Adagio Medical Treats First Patient with Faster, Single-Freeze Next-Generation ULTA System - Business Wire
Adagio Medical (ADGM) Analyst Ratings, Stock Forecast and Price Target - Moomoo
Adagio Medical Holdings (ADGM) Falls Nearly 10% as Support Level LoomsTrade Entry Signals - dars.gov.et
Sio Capital trims Adagio Medical (ADGM) holding to 3.15% under 5% threshold - Stock Titan
ADGM|Adagio Medical Holdings Inc|Price:0.485|Chg%:+0.003 - TradingKey
Adagio Medical Holdings Inc - TradingKey
Adagio Medical Holdings Inc (ADGM) Cash Flow - TradingKey
Adagio Medical Holdings Inc (ADGM) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Adagio Medical Holdings Inc (ADGM) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Adagio Medical Holdings Inc (ADGM) Institutional Confidence - TradingKey
Adagio Medical Holdings, Inc Revenue Breakdown – NASDAQ:ADGM - TradingView
Adagio Medical Holdings Inc|Price:0.482|Chg%:-0.008 - TradingKey
TradingKey - TradingKey
ADGM Q1 2026 Earnings: EPS Misses Estimates Amid Ongoing Development PhaseRevenue Beat Analysis - Vinanet
Adagio Medical Holdings Inc (ADGM) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
ADGM Q1 2026 Earnings: Wider-than-Expected Loss as Pre-Revenue Biotech Advances PipelineManagement Guidance Update - Vinanet
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
Frontier tech research, news & data - MLQ.ai
ADGM Q1 2026 Earnings: Wider-than-Expected Loss as Pre-Revenue Company Continues DevelopmentEnergy Earnings Report - dars.gov.et
ADGM Q1 2026 Earnings: Wider-Than-Expected Loss Reflects Ongoing R&D InvestmentEnergy Earnings Report - dars.gov.et
Adagio Medical Holdings, Inc. Files Amended 10-K/A Annual Report for 2025 – Key SEC Filing Details and Company Information – Minichart - Minichart
[10-K/A] Adagio Medical Holdings, Inc. Amends Annual Report - Stock Titan
Finanzdaten der Adagio Medical Holdings Inc-Aktie (ADGM)
Umsatz
Nettogewinn
Free Cashflow
ENV
Adagio Medical Holdings Inc-Aktie (ADGM) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Usen Todd | Chief Executive Officer |
Dec 12 '25 |
Buy |
1.09 |
207,315 |
225,973 |
207,315 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):